Home > Conferences & symposia > NRS webinar > NRS Webinar-Chips in Respiratory Disease

NRS Webinar-Chips in Respiratory Disease

NRS webinar-"Innovative Approaches in Lung Cancer" 29 August 12:30-13:30. 

Invited speakers

 

Dr. Anne van der Does

Development of Lung-on-Chip models to study tissue damage and repair"

 

Dr. Ramon Langen

 

Dr. Anne van der Does, Ph.D. is an Associate Professor at the Department of Pulmonology at the Leiden University Medical Center in the Netherlands. Her work is focused on (dysfunctional) lung epithelial biology in chronic lung diseases, with specific focus on developing advanced lung epithelial cell cultures to support that research. Related to this focus, dr. van der Does was awarded a Marie Curie fellowship twice, of which the second included a one-year visit at Emulate Inc. -a pioneer company in Organs-on-Chips technology- to use their Lung-on-Chip platform. Dr. van der Does has published in peer-review journals including the European Respiratory Journal.  is a Physician-Scientist in the Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute, Assistant Professor of Medicine at Harvard Medical School, and the Principal Investigator of a research laboratory within the Division of Molecular and Cellular Oncology at the Dana-Farber Cancer Institute. Dr. Oser obtained a Bachelor of Arts from Oberlin College, and a Doctor of Medicine and Doctor of Philosophy from Albert Einstein College of Medicine. He completed his residency in internal medicine at Brigham and Women’s Hospital, and was a Medical Oncology Fellow in the Dana-Farber/Partners Cancer Care program. In2019, following completion of a post doctoral fellowship in the lab of William G. Kaelin Jr., MD at Dana-Farber Cancer Institute and Harvard Medical School, he began a tenure-track independent investigator position in the Division of Molecular and Cellular Oncology where he heads an independent research laboratory, and a clinical position within the Lowe Center for Thoracic Oncology.

Dr. van der Does received her Ph.D. from the Department of Infectious Diseases at the LUMC before completing a 4-year postdoc at the Karolinska Institutet, in Stockholm, Sweden after which she continued her career in the PulmoScience Lab of the LUMC (www.pulmosciencelableiden.com).